Healthtech Startups

Fortis Therapeutics develops therapeutic treatments based on technology licensed from UCSF, with a focus on oncology and other disease areas. The company is backed by multiple life sciences investment firms and operates from San Diego.

3 investors

Fortive is a global industrial technology company that develops products for medical device safety, radiation protection, workflow automation, gas detection, and predictive maintenance. It serves healthcare providers and industrial operations where safety and productivity are priorities.

3 investors

Fortuna modernizes the infrastructure and consumer experience for Medicaid and government health programs. The company focuses on improving enrollment, eligibility verification, and access to coverage for Medicaid, CHIP, and Marketplace beneficiaries.

3 investors

FoRx Therapeutics is a biotechnology company focused on oncology drug discovery and clinical development, targeting the DNA Damage Response (DDR) network with small molecule inhibitors. Its work centers on cancer therapeutics developed by a team with pharma and biotech backgrounds.

3 investors

Fourier Health builds infrastructure to unlock unstructured clinical data from healthcare systems, enabling AI models and clinicians to access actionable intelligence from records currently locked in PDFs and fragmented systems. The company serves healthcare providers, researchers, and AI developers seeking trustworthy clinical data integration and analysis.

3 investors

Freeline develops gene therapies aimed at stopping the progression of chronic diseases with single-dose genetic medicines. Its pipeline spans rare conditions such as Gaucher disease and moves toward more widespread conditions including forms of Parkinson's, dementia, and certain cardiovascular diseases.

3 investors

Freespira develops an FDA-indicated medical device combined with clinical support for treating PTSD and panic disorder symptoms at home over 28 days. The solution serves health plans, healthcare providers, and self-insured employers seeking to improve patient outcomes and optimize healthcare resource utilization.

3 investors

Friday Health Plans was a group of state-based health insurance companies operating in Colorado, Georgia, Nevada, North Carolina, Oklahoma, and Texas. The company is now in court-administered liquidation, with the page providing information for members and providers about the receivership process.

3 investors

Fundly.ai operates a fintech platform combining commerce, payments and working-capital credit for pharmaceutical retailers, distributors and brands in India. The company offers purchase optimization, usage-based interest payments, and unsecured working capital to support the pharma retail supply chain.

3 investors

Fuse uses AI and automation to provide price transparency in US healthcare by determining accurate insurance benefits, detecting underpayments, and delivering cost estimates to patients before treatment. The company serves healthcare providers and patients seeking clarity on medical costs and payment accuracy.

3 investors

Future provides AI-powered personalized coaching for fitness and health, built around individual goals, body type, and schedule. The platform has completed over 8 million coaching sessions and aims to make world-class coaching accessible to a broader audience.

3 investors

Future Fertility develops an artificial intelligence tool to assess egg quality for fertility treatment using machine learning analysis of oocyte health. The company serves reproductive endocrinologists, embryologists, and patients undergoing IVF procedures.

3 investors

GAIA BioMedicine (株式会社ガイアバイオメディシン) develops GAIA-NK, a cell therapy using engineered cells with high cytotoxic activity against solid tumors, based on research from Kyushu University. The company researches, develops, and manufactures regenerative medicine products aimed at curative cancer treatment.

3 investors

Galera Therapeutics is a biotechnology company developing antibody-based and other therapeutics. This page profiles Dr. Nancy Chang, a member of the company's Board of Directors.

3 investors

Ganance makes The Heir, a device that clips to existing watches using microsuction technology to collect health data without sacrificing style or requiring a smartwatch. The product serves watch enthusiasts and health-conscious consumers who want to track their wellness data without compromising their preferred timepiece.

3 investors

Gather Health provides primary care services with integrated social and home-based support for older adults in underserved communities. The company operates physical centers that combine medical care with community programs focused on connection, education, and wellness.

3 investors

Gelatex Technologies develops nanofiber production technology for use in food production, medical applications, and sustainable materials. The company focuses on creating materials with lower environmental impact across multiple industrial sectors.

3 investors

Gencove provides direct-to-consumer genetic sequencing and polygenic risk scoring for health insights. The service analyzes DNA samples to deliver personalized health recommendations across core health areas, ancestry information, and integrates with labs, wearables, and lifestyle data.

3 investors

Skyline Therapeutics develops gene therapy vector technology and supports clinical development for therapeutic applications using genetic science approaches.

3 investors

Genenta Science is a clinical-stage biotechnology company developing Temferon, a hematopoietic stem cell-based gene therapy platform for treating cancer. The company is publicly traded on Nasdaq under the ticker GNTA.

3 investors

Genexa develops over-the-counter medicines formulated with the same active ingredients as conventional drugs but without artificial fillers, using what it describes as clean ingredients. The consumer health brand was founded by two fathers and markets its products to families.

3 investors

Genie Fertility develops a discovery platform that uses machine learning and multi-omics analysis to identify molecular biomarkers in uterine lining, leveraging menstrual blood samples to improve reproductive health outcomes and fertility diagnostics. The platform aims to address the high failure rate of IVF by providing better understanding of endometrial health, which can account for up to one-quarter of infertility issues.

3 investors

Genomic Health develops diagnostic tests and related services and runs health-equity initiatives aimed at improving access, awareness, and outcomes for patients and communities, including uninsured and underinsured populations. The company focuses on making its tests inclusive through diverse clinical trials, patient education, and community partnerships.

3 investors

LifeView, operated by Genomic Prediction, offers preimplantation genetic testing (PGT) for IVF embryos, including screening for aneuploidy, monogenic disorders, structural rearrangements, and polygenic disease risk. Its tests serve fertility clinics and IVF patients to help select embryos for transfer.

3 investors